Maria Grazia Ruo Redda

Long-term follow-up of cervical cancer patients: a retrospective analysis of treatment-related toxicities

Roberta Massobrio, Virginia Giacomini, Luca Fuso, Beatrice Campigotto et autres

it (code pays fourni par la source)

Pseudoprogression and improvement of quality of life in a patient with advanced endometrial cancer treated with immunotherapy: a case report

Valentina Tuninetti, Roberta Danese, Amedeo Calvo, Marco Bellero et autres

Special Issue: https://www.drugsincontext.com/special_issues/new-treatment-options-for-advanced-endometrial-carcinoma.

it (code pays fourni par la source)

Can Deep Learning-Based Auto-Contouring Software Achieve Accurate Pelvic Volume Delineation in Volumetric Image-Guided Radiotherapy for Prostate Cancer? A Preliminary Multicentric Analysis

Cristiano Grossi, Fernando Muñoz, Ilaria Bonavero, Eulalie Joelle Tondji Ngassam et autres

Background: Radiotherapy (RT) is a mainstay treatment for prostate cancer (PC). Accurate delineation of organs at risk (OARs) is crucial for optimizing the therapeutic window by minimizing side effects. Manual segmentation is time-consuming and prone to inter-operator variability. This study investigates the …

it (code pays fourni par la source)

Salivary Gland Scintigraphy in Parotid-Sparing IMRT for H&N Cancer: Trend of Function Recovery

Alessia Reali, T. Angusti, Edoardo Trevisiol, Simona Allis et autres

it (code pays fourni par la source)

New Frontiers in Locally Advanced Cervical Cancer Treatment

Roberta Massobrio, Lavinia Bianco, Beatrice Campigotto, Daniela Attianese et autres

Despite the introduction of targeted vaccines and screening protocols, locally advanced cervical cancer represents a median proportion of 37% among all cervical carcinomas. Compared to early stages, it presents significantly lower cure rates, with a 5-year disease-free survival rate of 68% and …

it (code pays fourni par la source)

Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer

Giovannino Ciccone, Stefano De Luca, Marco Oderda, F. Muñoz et autres

Importance: Although active surveillance for patients with low-risk prostate cancer (LRPC) has been recommended for years, its adoption at the population level is often limited. Objective: To make active surveillance available for patients with LRPC using a research framework and to compare …

it, us (code pays fourni par la source)

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Claire Petit, Benjamin Lacas, Jean‐Pierre Pignon, Quynh‐Thu Le et autres

fr, us, dk, gb, se, it, ca, es, pl, de, au, in, cn, be, ch (code pays fourni par la source)

Graves' orbitopathy: a multidisciplinary approach

Paolo Limone, Marco Mellano, Maria Grazia Ruo Redda, Annalisa Macera et autres

Orbitopathy is the main extra thyroidal manifestation of Graves' disease. It is a very challenging condition, which requires a cooperation between many specialists (endocrinologists, ophthalmologists, radiologists, radiotherapeutic, orbital surgeons) for an optimal clinical management. An accurate diagnostic assessment is required, in order …

it (code pays fourni par la source)

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

Benjamin Lacas, Alexandra Carmel, C. Landais, Stuart J. Wong et autres

BACKGROUND AND PURPOSE: The Meta-Analysis of Chemotherapy in squamous cell Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) improved overall survival (OS) in patients without distant metastasis. We report the updated results. MATERIALS AND METHODS: Published or unpublished randomized trials …

us, fr, ch, no, in, be, es, it, gb, ca, nl (code pays fourni par la source)

Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?

Paolo Limone, Lavinia Bianco, Marco Mellano, Francesca Garino et autres

it (code pays fourni par la source)

Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer

C. Fiandra, Linda Rossi, A. Alparone, Stefania Zara et autres

it, by, nl (code pays fourni par la source)

Volumetric radiation therapy and IGRT with kV-CBCT and Calypso in prostate cancer: experiences of technical-practical training in comparison

Federica Fenoglio, Maria Grazia Ruo Redda, Katri Kela, Aino-Liisa Jussila